Rui Batista

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Marion Detroit, Mathis Collier, Nathanaël Beeker, Lise Willems, Justine Decroocq, Benedicte Deau, Marguerite Vignon, Rudy Birsen, Frederique Moufle, Clément Leclaire, Elisabeth Balladur, Paul Deschamps, Adrien Chauchet, Rui Batista, Samuel Limat, Jean-Marc Treluyer, Laure Ricard, Nicolas Stocker, Olivier Hermine, Sylvain Choquet, Véronique Morel, Carole Metz, Didier Bouscary, Marie Kroemer, Jérémie Zerbit
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM). Cancers 15 (16) (2023)
Jeremie Zerbit, Marion Detroit, Antoine Meyer, Justine Decroocq, Benedicte Deau, Paul Deschamps, Rudy Birsen, Johanna Mondesir, Patricia Franchi, Elsa Miekoutima, Corinne Guerin, Rui Batista, Didier Bouscary, Lise Willems, Marguerite Vignon
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era. Viruses 14 (11) (2022)
Jérémie Zerbit, Jerome Tamburini, Lauriane Goldwirt, Justine Decroocq, Jean Michel Cayuela, Nicolas Chapuis, Adrien Contejean, Rui Batista, Didier Bouscary, Lise Willems
Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia & lymphoma (2021)

Rui Batista.css-eqlu8i{font-size:small;padding-left:4px;}